Cargando…
Camel nanobody-based B7-H3 CAR-T cells show high efficacy against large solid tumours
Rational design of chimeric antigen receptor T (CAR-T) cells based on the recognition of antigenic epitopes capable of evoking the most potent CAR activation is an important objective in optimizing immune therapy. In solid tumors, the B7-H3 transmembrane protein is an emerging target that harbours t...
Autores principales: | Li, Dan, Wang, Ruixue, Liang, Tianyuzhou, Ren, Hua, Park, Chaelee, Tai, Chin-Hsien, Ni, Weiming, Zhou, Jing, Mackay, Sean, Edmondson, Elijah, Khan, Javed, Croix, Brad St, Ho, Mitchell |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10517151/ https://www.ncbi.nlm.nih.gov/pubmed/37739951 http://dx.doi.org/10.1038/s41467-023-41631-w |
Ejemplares similares
-
CAMEL NANOBODY-BASED B7-H3 CAR-T CELLS WITH HIGH EFFICACY AGAINST SOLID TUMORS
por: Li, Dan, et al.
Publicado: (2023) -
IMMU-20. EVALUATION OF B7-H3 NANOBODY CAR-T CELLS IN PEDIATRIC GLIOBLASTOMA
por: Fanuzzi, Mia, et al.
Publicado: (2023) -
Camel nanobodies broadly neutralize SARS-CoV-2 variants
por: Hong, Jessica, et al.
Publicado: (2021) -
Dromedary camel nanobodies broadly neutralize SARS-CoV-2 variants
por: Hong, Jessica, et al.
Publicado: (2022) -
CAMEL NANOBODIES NEUTRALIZE SARS-COV-2 VARIANTS
por: Hong, Jessica, et al.
Publicado: (2023)